ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 91 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,669,000 | +37.8% | 5,451,400 | -1.0% | 0.00% | +33.3% |
Q4 2018 | $4,115,000 | -65.9% | 5,506,300 | -3.4% | 0.00% | -62.5% |
Q3 2018 | $12,081,000 | -6.0% | 5,698,700 | +2.4% | 0.01% | -20.0% |
Q2 2018 | $12,852,000 | -27.4% | 5,563,700 | -0.1% | 0.01% | -23.1% |
Q1 2018 | $17,703,000 | -22.4% | 5,566,900 | +0.0% | 0.01% | -27.8% |
Q4 2017 | $22,819,000 | -9.3% | 5,565,600 | -0.0% | 0.02% | -14.3% |
Q3 2017 | $25,158,000 | +36.0% | 5,565,900 | +0.2% | 0.02% | +31.2% |
Q2 2017 | $18,493,000 | +5.3% | 5,553,600 | +191.3% | 0.02% | 0.0% |
Q1 2017 | $17,560,000 | +26.5% | 1,906,600 | +5.9% | 0.02% | +14.3% |
Q4 2016 | $13,883,000 | -6.8% | 1,800,700 | +38.2% | 0.01% | -6.7% |
Q3 2016 | $14,890,000 | +460.6% | 1,302,700 | +503.7% | 0.02% | +400.0% |
Q2 2016 | $2,656,000 | +21.7% | 215,800 | 0.0% | 0.00% | +50.0% |
Q1 2016 | $2,182,000 | -49.5% | 215,800 | +12.5% | 0.00% | -50.0% |
Q4 2015 | $4,323,000 | +36.6% | 191,800 | +0.5% | 0.00% | 0.0% |
Q3 2015 | $3,165,000 | -26.3% | 190,800 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $4,293,000 | -19.3% | 190,800 | -7.5% | 0.00% | -20.0% |
Q1 2015 | $5,318,000 | +11.9% | 206,293 | -5.5% | 0.01% | 0.0% |
Q4 2014 | $4,752,000 | +14.9% | 218,400 | 0.0% | 0.01% | +25.0% |
Q3 2014 | $4,134,000 | -33.4% | 218,400 | -18.0% | 0.00% | -42.9% |
Q2 2014 | $6,207,000 | -45.9% | 266,400 | -21.8% | 0.01% | -46.2% |
Q1 2014 | $11,465,000 | +14.0% | 340,700 | 0.0% | 0.01% | +8.3% |
Q4 2013 | $10,057,000 | +168.5% | 340,700 | +39.2% | 0.01% | +140.0% |
Q3 2013 | $3,746,000 | – | 244,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
Fondren Management LP | 25,136 | $26,000 | 0.02% |
Cannell & Co. | 281,983 | $293,000 | 0.01% |
APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |